They are talking about Mathew Ratty CEO of TMP.
He was also on the BOD at Admedus, shareholders are angry he sold down his position from Number 2 shareholder to who knows (no longer in the top 20) he had around 10 million shares.
The controversial part of it is, right in the midst of a SPP he resigned as director, and at some point between then and the next Top 20 was released he had started selling down his position.
Would it have made any difference to the outcome of Admedus? I don't think so, but still shitty for all holders and hopefully if anything dodgy was happening ASIC investigate but I'm guessing everything would be above board legally.
They are talking about Mathew Ratty CEO of TMP. He was also on...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AV1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.11M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 93408 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 26379 | 1 |
View Market Depth
| Last trade - 11.09am 25/07/2024 (20 minute delay) ? |
| AV1 (ASX) Chart |
Day chart unavailable